In the UK, a total of 62,809 patients with diabetes were found to have a higher risk of colon and pancreatic cancer compared to a similar population without diabetes. Diabetics who were also obese had the highest number of cancers.
Researchers at Addenbrooke’s Hospital in Cambridgeshire are developing a new metabolic scanning system that is hoped to allow doctors to determine how well a cancer treatment is working, as soon as one day after treatment.
Following the growing debate about the use of the prostate-specific antigen (PSA) test for prostate cancer and whether the age limit of 50 should be lowered, Public Health England (PHE) has issued new guidelines to general practitioners (GPs).
Doctors in the US say they are developing a new test that can show almost immediately whether chemotherapy is working. Eventually, the researchers hope patients will also be able to watch the disease being cleared from the body.
Scientists in Birmingham have devised a new and more accurate blood test to identify prostate cancer.